PHC Corporation Biomedical Division launches LiCellMo, a live cell metabolic analyzer that allows users to visualize metabolic changes in cell cultures, providing a more complete picture of cell activity for use in cell and gene therapies (CGT). The need for precise analysis of metabolic changes is important to support processes such as the transition from 2D cell culture techniques to more complex 3D cell culture methods, including organoids. By providing continuous and accurate metabolic data, the analyzer enables users to make more informed decisions, which helps contribute to novel findings and important advances in therapies. In addition, the LiCellMo can be easily installed in a laboratory’s existing CO₂ incubator with no changes to the usual culture environment. The system allows real-time visualization of changes in cell metabolism through continuous monitoring of glucose and lactate using proprietary In-Line sensors, and the use of preferred culture environment and culture medium with standard 24-well plates.